Microarray-based detection and expression analysis of ABC and SLC transporters in drug-resistant ovarian cancer cell lines

R Januchowski, P Zawierucha, M Andrzejewska… - Biomedicine & …, 2013 - Elsevier
Multiple drug resistance of cancer cells is multifactorial. A microarray technique may provide
information about new candidate genes playing a role in drug resistance. Drug membrane …

Jatrophane and rearranged jatrophane-type diterpenes: Biogenesis, structure, isolation, biological activity and SARs (1984–2019)

M Fattahian, M Ghanadian, Z Ali, IA Khan - Phytochemistry reviews, 2020 - Springer
Diterpene compounds specially macrocyclic ones comprising jatrophane, lathyrane,
terracinolide, ingenane, pepluane, paraliane, and segetane skeletons occurring in plants of …

Anti-cancer effects of cerium oxide nanoparticles and its intracellular redox activity

M Pešić, A Podolski-Renić, S Stojković… - Chemico-biological …, 2015 - Elsevier
Data on medical applications of cerium oxide nanoparticles CeO 2 (CONP) are promising,
yet information regarding their action in cells is incomplete and there are conflicting reports …

Antitumor activity of 1, 18-octadecanedioic acid-paclitaxel complexed with human serum albumin

CE Callmann, CLM LeGuyader, ST Burton… - Journal of the …, 2019 - ACS Publications
We describe the design, synthesis, and antitumor activity of an 18 carbon α, ω-dicarboxylic
acid monoconjugated via an ester linkage to paclitaxel (PTX). This 1, 18-octadecanedioic …

Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer

J Shen, Q Yin, L Chen, Z Zhang, Y Li - Biomaterials, 2012 - Elsevier
Drug resistance is a main obstacle for the successful chemotherapy of lung cancer. In this
work, a new co-delivery system, P85-PEI/TPGS/PTX/shSur complex nanoparticles (PTPNs) …

MDR gene expression analysis of six drug‐resistant ovarian cancer cell lines

R Januchowski, K Wojtowicz… - BioMed research …, 2013 - Wiley Online Library
Ovarian cancer is the leading cause of death among gynaecological malignancies. Multiple
drug resistance makes cancer cells insensitive to chemotherapy. In this study, we developed …

Drug transporter expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line

R Januchowski, P Zawierucha, M Ruciński… - Biomedicine & …, 2014 - Elsevier
Ovarian cancer is characterized by the higher mortality among gynecological cancers. In
results of MDR development during chemotherapy cancer cells become resistant to further …

Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines

R Januchowski, K Sterzyńska, K Zaorska… - Journal of ovarian …, 2016 - Springer
Background Multiple drug resistance (MDR) of cancer cells is the main reason of intrinsic or
acquired insensitivity to chemotherapy in many cancers. In this study we used ovarian …

Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancer

G Salzano, R Riehle, G Navarro, F Perche, G De Rosa… - Cancer letters, 2014 - Elsevier
The discovery that survivin, a small anti-apoptotic protein, is involved in chemoresistance,
opens a new scenario to overcome the drug resistance in cancer. It was shown that siRNA …

Elesclomol-Copper Nanoparticles Overcome Multidrug Resistance in Cancer Cells

Q Wang, C Huang, FS Wibowo, R Amin… - … Applied Materials & …, 2024 - ACS Publications
Elesclomol (ES), a copper-binding ionophore, forms an ES–Cu complex with copper ions
(Cu (II)). ES–Cu has been proven to induce mitochondrial oxidative stress and copper …